Announced last week, the Galien Foundation’s annual Prix Galien awards highlight devices, biotechnology and pharmaceutical products designed to improve the human condition.
“The outstanding quality of the submissions is a testament to the promising future of the life sciences industries,” said Former Johnson & Johnson CEO ChairAlex Gorsky — one of the awards jurors — in anews releaseannouncing the nominees.
Last year’s winnersincluded Cala Health, Abbott, Edwards Lifesciences and Roche. (See all of 2022’s nominees here, including many that were nominated again in 2023.)
“Each year, the Awards Committee is astounded by the growing number of applicants and the level of passion, creativity and determination from the nominees who are developing their ideas into highly desirable solutions for patients around the world,” said Prix Galien Committee Chair伯纳德Poussot -who led judging in the categories of medical technology, startups, digital health and incubators, accelerators and equity — when the winners were announced. “We applaud their unwavering commitment to improving the human condition and are honored to celebrate their achievements.”
Learn more about medtech innovations and medical device developers that won 2023 Prix GalienUSAAwards and nominations in the pages that follow.
Tell Us What You Think!
You must belogged into post a comment.